Haemair develops artificial device for lung disease patients

12/24/2008 | WalesOnline (U.K.)

Medical-technology firm Haemair has designed a synthetic lung that can "breathe" for individuals with chronic obstructive pulmonary disorder, including bronchitis and emphysema. The device may serve as an alternative to lung transplants and is expected to be used in clinical applications starting next year.

View Full Article in:

WalesOnline (U.K.)

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Food & Drug Associate
Washington, D.C., DC
Senior Manager, Gaps in Care
UAW Retiree Medical Benefits Trust
Detroit, MI
Compliance Director
Abbott Laboratories
Santa Clara, CA
Product Development Manager, Disposable Medical Products
ASAHI INTECC, Orange County CA R&D Center
Santa Ana, CA
Neurovascular Intervention Product Sales Rep, North East
Multiple Locations, SL_Multiple Locations